About the Financial Times The Financial Times is one of the world’s leading business news organisations, recognised internationally for its authority, integrity and accuracy. The FT has a record paying readership of one million, three-quarters of which are digital subscriptions. It is part of Nikkei Inc., which provides a broad range of information, news and services for the global business community. Learn more about the FT, including announcements and career opportunities, at aboutus.ft.com. Subscribe at subs.ft.com. One of the world’s leading business news organisations

Sectors: Media

Seed Investor. We invest in People. Venture Capital for High-Tech Founders. Made in Germany. The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise, entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros …

Sifted is the leading media brand for the European startup community, backed by the Financial Times. 👋 Welcome to Sifted — the only read you need for staying up to speed on startup Europe. Looking for the next big thing in tech? Or maybe you’ve got your eye on a specific sector? We’ll save you hours of research with Sifted Pro, our premium subscription, where you’ll get access to: 🔎 100+ Briefings: packed with proprietary data on emerging sectors and geographic hotspots — keeping you ahead of the competition. 🗓️ Monthly events: Source new business opportunities with rising stars and …

We advance science so that we all have more time with the people we love. Are you ready to join us? Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is …

Sectors: Biotechnology Pharmaceutical